Abstract
Allogeneic stem cell transplantation may induce lasting remissions in leukemia and hematological malignancies that otherwise are refractory to chemotherapy. An important role in the control of the disease is played by immune competent cells of the graft. This role has been most convincingly demonstrated by the effect of donor lymphocyte transfusions for the treatment of recurrent chronic myelogenous leukemia. In other forms of leukemia and hematological malignancies this role has been less clearly defined. In this chapter, strategies are discussed to improve the effect of donor lymphocyte transfusions. Methods to improve responses have involved the use of cytokines, natural killer cells, and antibodies.
Original language | English |
---|---|
Title of host publication | Stem Cell Transplantation |
Subtitle of host publication | Biology, Processing, and Therapy |
Publisher | Wiley-VCH Verlag GmbH & Co. KGaA |
Pages | 221-231 |
Number of pages | 11 |
ISBN (Print) | 3527310185, 9783527310180 |
DOIs | |
State | Published - 28 Aug 2006 |
Externally published | Yes |
Keywords
- Adoptive immunotherapy
- Animal experiments
- Bispecific antibodies
- Clinical applications
- Cytokines
- EBMT study
- First clinical results in CML
- Graft-versus-leukemia effect
- HLA-haploidentical transplantation
- NK and NK-T cells transplantation
- Stem cell biology
- Transplantation